Investor Presentaiton

Electromed Overview » Growing and profitable medical technology company >>> A leader in the large and expanding airway clearance market » SmartVest® High Frequency Chest Wall Oscillation ("HFCWO") technology supported by clinical outcomes data with strong reimbursement » Attractive direct-to-patient and provider model » Strong financial profile with attractive historical gross margins and profitability, well capitalized balance sheet Net Revenue ($M)¹ $48.1 $41.7 $35.8 $32.5 $31.3 $28.3 FY'18 FY'19 FY'20 FY'21 FY'22 FY'23 Net Income ($M)1 $4.2 $3.2 $2.4 $2.3 $2.0 $1.8 1 Financials under ASC 606 smartvest® AIRWAY CLEARANCE SYSTEM Investor Presentation FY'18 FY'19 FY'20 FY'21 FY'22 FY'23 ELECTROMED, INC. 14

View entire presentation